Dr Reddy's slips 7% following 8 USFDA observations for Duvvada plant
The stock slipped 7% to Rs 2,425 on the BSE after the pharmaceutical company said US health regulator issued eight observations after inspecting its formulations plant at Duvvada, Visakhapatnam.
No comments:
Post a Comment